D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.14% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.3% |
| 4 | Financials | 9.14% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Tucows
TCX
$97.1M
| $564K | ﹤0.01% |
9,305
+66
| +0.7% | +$4.1K |
|
3002
OrthoPediatrics
KIDS
$485M
| $563K | ﹤0.01% |
21,140
+5,159
| +32% | +$110K |
|
3003
Microvision
MVIS
$88.2M
| $563K | ﹤0.01% |
+502,516
| New | +$666K |
|
3004
CALL
Ameriprise Financial
AMP
$46.8B
| $560K | ﹤0.01% |
+4,000
| New | +$567K |
|
|
REGI
3005
DELISTED
Renewable Energy Group, Inc.
REGI
| $560K | ﹤0.01% |
31,388
-243,528
| -89% | -$3.77M |
|
3006
CALL
GoDaddy
GDDY
$12.3B
| $558K | ﹤0.01% |
+7,900
| New | +$537K |
|
|
CERN
3007
DELISTED
Cerner Corp
CERN
| $558K | ﹤0.01% |
9,337
-352,245
| -97% | -$20.8M |
|
3008
Camden National
CAC
$924M
| $557K | ﹤0.01% |
12,184
+3,576
| +42% | +$162K |
|
|
SKX
3009
DELISTED
Skechers
SKX
| $556K | ﹤0.01% |
18,527
-135,312
| -88% | -$4.33M |
|
3010
PUT
Williams Companies
WMB
$90.5B
| $556K | ﹤0.01% |
+20,500
| New | +$541K |
|
3011
PUT
World Acceptance Corp
WRLD
$950M
| $555K | ﹤0.01% |
+5,000
| New | +$546K |
|
|
GOOD
3012
Gladstone Commercial Corp
GOOD
$627M
| $554K | ﹤0.01% |
+28,806
| New | +$524K |
|
3013
CALL
Canadian Solar
CSIQ
$906M
| $551K | ﹤0.01% |
+45,000
| New | +$676K |
|
3014
CALL
Nice
NICE
$5.29B
| $550K | ﹤0.01% |
+5,300
| New | +$537K |
|
3015
Artivion
AORT
$1.23B
| $549K | ﹤0.01% |
19,696
-12,463
| -39% | -$314K |
|
3016
Marriott Vacations Worldwide
VAC
$3.24B
| $549K | ﹤0.01% |
4,862
-8,316
| -63% | -$1.03M |
|
|
XLRN
3017
DELISTED
Acceleron Pharma
XLRN
| $547K | ﹤0.01% |
+11,282
| New | +$411K |
|
|
LTS
3018
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $547K | ﹤0.01% |
160,974
+24,697
| +18% | +$86.5K |
|
3019
CALL
Rogers Corp
ROG
$2.33B
| $546K | ﹤0.01% |
4,900
-6,000
| -55% | -$701K |
|
3020
PUT
International Flavors & Fragrances
IFF
$19.4B
| $545K | ﹤0.01% |
+4,400
| New | +$575K |
|
3021
Exponent
EXPO
$2.98B
| $544K | ﹤0.01% |
11,257
-37,679
| -77% | -$1.73M |
|
|
DBD
3022
DELISTED
Diebold Nixdorf Incorporated
DBD
| $544K | ﹤0.01% |
45,510
-408,569
| -90% | -$5.47M |
|
3023
MakeMyTrip
MMYT
$4.67B
| $543K | ﹤0.01% |
15,009
+5,014
| +50% | +$180K |
|
3024
CALL
Cullen/Frost Bankers
CFR
$10.3B
| $541K | ﹤0.01% |
5,000
+2,500
| +100% | +$282K |
|
3025
Ingevity
NGVT
$2.55B
| $541K | ﹤0.01% |
+6,695
| New | +$532K |
|
Similar funds
D.E. Shaw & Co's Q2 2018 Portfolio in Review
As of Q2 2018, D.E. Shaw & Co held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- D.E. Shaw & Co added most to Amazon in Q2 2018, an estimated $696M increase.
- D.E. Shaw & Co's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- D.E. Shaw & Co fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- D.E. Shaw & Co opened 622 new positions and closed 399 in Q2 2018.
- D.E. Shaw & Co's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.